The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55)

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5143-5152

  Karnauchow, Timothy M ^a   Tolson, Douglas L ^b   Harrison, Blair A ^b   Altman, Eleonora ^b   Lublin, Douglas M ^c   Dimock, Kenneth ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; DECAY ACCELERATING FACTOR; MONOCLONAL ANTIBODY; RECEPTOR ANTIBODY; SULFUR 35;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CELL SPECIFICITY; CELL STRAIN 3T3; CHO CELL; ENTEROVIRUS; HELA CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PICORNAVIRUS; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0030001107     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5143-5152.1996     Document Type: Article

References (57)

1. Abraham, G., and R. J. Colonno. 1984. Many rhinovirus serotypes share the same cellular receptor. J. Virol. 51:340-345.
2. Bass, D. M., and H. B. Greenberg. 1992. Strategies for the identification of icosahedral virus receptors. J. Clin. Invest. 89:3-9.
3. Bergelson, J. M., M. Chan, K. R. Solomon, N. F. St. John, H. Lin, and R. W. Finberg. 1994. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. USA 91:6245-6248.
4. Bergelson, J. M., and R. W. Finberg. 1993. Integrins as receptors for virus attachment and cell entry. Trends Microbiol. 1:287-288.
5. Bergelson, J. M., J. G. Mohanty, R. L. Crowell, N. F. St. John, D. M. Lublin, and R. W. Finberg. 1995. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol. 69:1903-1906.
6. Bergelson, J. M., M. P. Shepley, B. M. C. Chan, M. E. Hemler, and R. W. Finberg. 1992. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 255:1718-1720.
7. 2 subunit of human VLA-2. J. Virol. 67:6847-6852.
8. 3) inhibit binding and infection of foot-and-mouth disease virus to cultured cells. J. Virol. 69:2664-2666.
9. Clarkson, N. A., R. Kaufman, D. M. Lublin, T. Ward, P. A. Pipkin, P. D. Minor, D. J. Evans, and J. W. Almond. 1995. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J. Virol. 69: 5497-5501.
10. Coyne, K. E., S. E. Hall, E. S. Thompson, M. A. Arce, T. Kinoshita, T. Fujita, D. J. Anstee, W. Rosse, and D. M. Lublin. 1992. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149:2906-2913.
11. Darougar, S., M. A. Monnickendam, and R. M. Woodland. 1989. Management and prevention of ocular viral and chlamydial infections. Crit. Rev. Microbiol. 16:369-418.
12. Davitz, M. A., M. G. Low, and V. Nussenzweig. 1986. Release of decayaccelerating factor (DAF) from the cell membrane by phosphatidylinositol-specific phospholipase C (PIPLC). Selective modification of a complement regulatory protein. J. Exp. Med. 163:1150-1161.
13. Dimock, K., D. G. Harnish, G. Sisson, W.-C. Leung, and W. E. Rawls. 1982. Synthesis of virus-specific polypeptides and genomic RNA during the replicative cycle of Pichinde virus. J. Virol. 43:273-283.
14. Engvall, E., and P. Perlmann. 1971. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8:871-874.
15. Greve, J. M., G. Davis, A. M. Meyer, C. P. Forte, S. C. Yost, C. W. Marlor, M. E. Kamarck, and A. McClelland. 1989. The major human rhinovirus receptor is ICAM-1. Cell 56:839-847.
16. Hansen, M. B., S. E. Nielsen, and K. Berg. 1989. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119:203-210.
17. Higgins, P. G. 1982. Enteroviral conjunctivitis and its neurological complications. Arch. Virol. 73:91-101.
18. Hofer, F., M. Gruenberger, H. Kowalski, H. Machat, M. Huettinger, E. Kuechler, and D. Blaas. 1994. Members of the low density lipoprotein receptor family mediate cell entry of a minor group common cold virus. Proc. Natl. Acad. Sci. USA 91:1839-1842.
19. Hornbeck, P. 1991. Antibody-sandwich ELISA to detect soluble antigens, p. 2.1.9-2.1.11. In J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach. and W. Strober (ed.), Current protocols in immunology, vol. 1. John Wiley & Sons, Inc., New York.
20. Huber, S. A. 1994. VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells. J. Virol. 68:3453-3458.
21. Johnson, R. T. 1994. The Soriano Award Lecture. Emerging infections of the nervous system. J. Neurol. Sci. 124:2-14.
22. Kaufman, R., and D. Lublin. Unpublished observation.
23. King, S. L., J. A. Cunningham, R. W. Finberg, and J. M. Bergelson. 1995. Echovirus 1 interaction with the isolated VLA-2 domain. J. Virol. 69:3237-3239.
24. Köhler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibodies of predefined specificity. Nature (London) 256:495-497.
25. Kono, R., A. Sasagawa, K. Ishii, M. Ochi, S. Sugiura, H. Matsumiya, Y. Uchida, K. Kameyama, M. Kaneko, and N. Sakurai. 1972. Pandemic of a new type of conjunctivitis. Lancet i:1191-1194.
26. Kono, R., E. Tajiri, K. Miyamura, A. Sasagawa, and T. Tsuruhara. 1978. Hemagglutination and hemagglutination inhibition tests with enterovirus type 70. J. Clin. Microbiol. 7:595-598.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
28. Lublin, D. M., and J. P. Atkinson. 1989. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 7:35-58.
29. Lublin, D. M., and K. E. Coyne. 1991. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J. Exp. Med. 174:35-44.
30. Medof, M. E., D. M. Lublin, V. M. Holers, D. J. Ayers, R. R. Getty, J. F. Leykam, J. P. Atkinson, and M. L. Tykocinski. 1987. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc. Natl. Acad. Sci. USA 84:2007-2011.
31. Medof, M. E., E. I. Walter, W. L. Roberts, R. Haas, and T. L. Rosenberry. 1986. Decay accelerating factor of complement is anchored to cells by a C-terminal glycolipid. Biochemistry 25:6740-6747.
32. Medof, M. E., E. I. Walter, J. L. Rutgers, D. M. Knowles, and V. Nussenzweig. 1987. Identification of the complement decay-accelerating factor (DAF) on epithelium and glandular cells and in body fluids. J. Exp. Med. 165:848-864.
33. Mendelsohn, D. L., E. Wimmer, and V. R. Racaniello. 1989. Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell 56:855-865.
34. Mims, C. A. 1986. Virus receptors and cell tropisms. J. Infect. 12:199-203.
35. Nicholson-Weller, A. 1992. Decay accelerating factor (CD55). Curr. Top. Microbiol. Immunol. 178:8-30.
36. Nicholson-Weller, A., J. Burge, and K. F. Austen. 1981. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical C3 convertase, C4b2a. J. Immunol. 127:2035-2039.
37. Nicholson-Weller, A., J. Burge, D. T. Fearon, P. F. Weller, and K. F. Austen. (1982). Isolation of a human erythrocyte membrane glycoprotein with decayaccelerating activity for C3 convertases of the complement system. J. Immunol. 129:184-189.
38. Nicholson-Weller, A., and C. E. Wang. 1994. Structure and function of decay accelerating factor CD55. J. Lab. Clin. Med. 123:485-491.
39. Norkin, L. C. 1995. Virus receptors: implications for pathogenesis and the design of antiviral agents. Clin. Microbiol. Rev. 8:293-315.
40. Raab de Verdugo, U., H.-C. Selinka, M. Huber, B. Kramer, J. Kellermann, P. H. Hofschneider, and R. Kandolf. 1995. Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J. Virol. 69:6751-6757.
41. 3 integrin, the vibronectin receptor. Virology 203:357-365.
42. Rolbart, H. A., and K. Kirkegaard. 1992. Picornavirus pathogenesis: viral access, attachment and entry into susceptible cells. Semin. Virol. 3:483-499.
43. Shafren, D. R., R. C. Bates, M. V. Agrez, R. L. Herd, G. F. Burns, and R. D. Barry. 1995. Coxsackieviruses B1, B3, and B5 use decay-accelerating factor as a receptor for cell attachment. J. Virol. 69:3873-3877.
44. Shepley, M. P., and V. R. Racaniello. 1994. A monoclonal antibody that blocks poliovirus attachment recognizes the lymphocyte homing receptor CD44. J. Virol. 68:1301-1308.
45. Schulman, M., C. D. Wilde, and G. Kohler. 1978. A better cell line for making hybridomas secreting specific antibodies. Nature (London) 276:269-271.
46. Spicer, A. P., M. F. Seldin, and S. J. Gendler. 1995. Molecular cloning and chromosomal localization of the mouse decay-accelerating factor genes. J. Immunol. 155:3079-3091.
47. Slanway, G. 1990. Structure, function and evolution of picornaviruses. J. Gen.Virol. 71:2483-2501.
48. Staunton, D. E., V. J. Merluzzi, R. Rothlein, R. Barton, S. D. Marlin, and T. A. Springer. 1989. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56:849-853.
49. Sugita, Y., M. Uzawa, and M. Tomila. 1987. Isolation of decay-accelerating factor (DAF) from rabbit erythrocyte membranes. J. Immunol. Methods 104:123-130.
50. Towbin, J., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
51. Utagawa, E. T., K. Miyamura, A. Mukoyama, and R. Kono. 1982. Neuraminidase-sensitive erythrocyte receptor for enterovirus type 70. J. Gen. Virol. 63:141-148.
52. Ward, T., P. A. Pipkin, N. A. Clarkson, D. M. Stone, P. D. Minor, and J. W. Almond. 1994. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 13:5070-5074.
53. White, D. J. G., T. Oglesby, M. K. Liszewski, I. Tedja, D. Hourcade, M.-W. Wang, L. Wright, J. Wallwork, and J. P. Atkinson. 1992. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant. Proc. 24:474-476.
54. White, J. M., and D. R. Littman. 1989. Viral receptors of the immunoglobulin superfamily. Cell 56:725-728.
55. Wright, P. D., G. H. Strauss, and M. P. Langford. 1992. Acute hemorrhagic conjunctivitis. Am. Fam. Physician 45:173-178.
56. Yamazaki, S., and K. Miyamura. 1989. General characteristics of enterovirus 70, p. 345-357. In Y. Uchida, K. Ishii, K. Miyamura, and S. Yamazaki (ed.), Acute hemorrhagic conjunctivitis. Etiology, epidemiology and clinical manifestations. S. Karger AG, New York.
57. Yoshii, T., K. Natori, and R. Kono. 1977. Replication of enterovirus 70 in nonprimate cell cultures. J. Gen. Virol. 36:377-384.